Targeting IL-23 Pathways: Evolving Biologic Strategies in IBD
Michael Dolinger, MD, MBA
David T. Rubin, MD
Defining Success in IBD: Treat-to-Target
Florence Odufalu, MD
Ugo Iroku, MD, MHS
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
Where Conventional IBD Therapies Fall Short
Beyond One-Size-Fits-All: Individualizing First-Line IBD Treatment
Gut-Selective Therapy: Understanding Anti-Integrins in IBD
The Evolving Role of Small Molecules in IBD Care
Setting the Stage: Why Rethinking IBD Care Matters Now
IBD in Focus: A Case-Based Approach to Diagnosis and Assessment
Understanding the Microbiome’s Role in IBD Management
Genetic Susceptibility in IBD: From Risk Genes to Clinical Impact
IBD Masterclass: Foundations of Pathophysiology and Targeted Therapy
IBD Beyond Symptoms: What Community GIs Need to Know
Targeting Inflammation in IBD: Localized vs Systemic Strategies
Case Review: Can You Crack This IBD Case?
David Rubin, MD
Kimberly D. Orleck, PA-C
Tailoring Treatment: Can You Select the Best Therapy?
Brooke Hodnick, PA-C, MPAS
Diagnosing IBD: Is It IBD or Something Else? Can You Tell?
Jennifer Geremia, PA-C
Loading...
We're glad to see you're enjoying Crohn's Colitis Professional… but how about a more personalized experience?
Press cancel to remain on Crohn's Colitis Professional. Press the link below or the continue button to keep going.